Salud financiera de hoja de balance de Amedisys
Salud financiera controles de criterios 5/6
Amedisys tiene unos fondos propios totales de $1.1B y una deuda total de $374.7M, lo que sitúa su ratio deuda/fondos propios en 34.3%. Sus activos y pasivos totales son $2.0B y $933.9M respectivamente. Amedisys El EBIT de la empresa es de $193.8M, por lo que su ratio de cobertura de intereses es de 7.4. Su tesorería e inversiones a corto plazo ascienden a $78.1M.
Información clave
33.0%
Ratio deuda-patrimonio
US$369.28m
Deuda
| Ratio de cobertura de intereses | 6.9x |
| Efectivo | US$126.45m |
| Patrimonio | US$1.12b |
| Total pasivo | US$940.39m |
| Activos totales | US$2.06b |
Actualizaciones recientes sobre salud financiera
Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25
We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Recent updates
Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 41% Discount?
Apr 10Does Amedisys (NASDAQ:AMED) Have A Healthy Balance Sheet?
Feb 25Amedisys (NASDAQ:AMED) Will Be Hoping To Turn Its Returns On Capital Around
Feb 10At US$83.54, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jan 03A Look At The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Dec 16Capital Allocation Trends At Amedisys (NASDAQ:AMED) Aren't Ideal
Nov 12Is Now The Time To Look At Buying Amedisys, Inc. (NASDAQ:AMED)?
Sep 19An Intrinsic Calculation For Amedisys, Inc. (NASDAQ:AMED) Suggests It's 38% Undervalued
Sep 04Amedisys: ROIC, Tangible Book Value Each Softening
Aug 24Slowing Rates Of Return At Amedisys (NASDAQ:AMED) Leave Little Room For Excitement
Aug 04Amedisys profit beats by $0.24, revenue misses by $25.23M, 2022 guidance below estimates
Jul 27We Think Amedisys (NASDAQ:AMED) Can Stay On Top Of Its Debt
Jul 20At US$115, Is It Time To Put Amedisys, Inc. (NASDAQ:AMED) On Your Watch List?
Jun 04Returns On Capital At Amedisys (NASDAQ:AMED) Have Stalled
May 05Is Amedisys, Inc. (NASDAQ:AMED) Trading At A 40% Discount?
Apr 20Does Amedisys (NASDAQ:AMED) Deserve A Spot On Your Watchlist?
Apr 06Is Amedisys (NASDAQ:AMED) A Risky Investment?
Feb 20Amedisys (NASDAQ:AMED) Shareholders Will Want The ROCE Trajectory To Continue
Jan 19Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
Dec 03These 4 Measures Indicate That Amedisys (NASDAQ:AMED) Is Using Debt Safely
Nov 18Amedisys (NASDAQ:AMED) Could Easily Take On More Debt
Aug 18Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Jul 23Amedisys: Strategic Contessa Acquisition Underpins The Home Healthcare Growth Opportunity
Jul 18Under The Bonnet, Amedisys' (NASDAQ:AMED) Returns Look Impressive
Jun 28It Looks Like Shareholders Would Probably Approve Amedisys, Inc.'s (NASDAQ:AMED) CEO Compensation Package
Jun 02Should You Be Adding Amedisys (NASDAQ:AMED) To Your Watchlist Today?
May 24Calculating The Fair Value Of Amedisys, Inc. (NASDAQ:AMED)
Apr 14Análisis de la situación financiera
Pasivos a corto plazo: AMEDLos activos a corto plazo ($496.9M) de la empresa superan a sus pasivos a corto plazo ($473.7M).
Pasivo a largo plazo: AMEDLos activos a corto plazo ($467.2M) superan a sus pasivos a largo plazo ($465.8M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: AMED(27.1%) se considera satisfactoria.
Reducción de la deuda: AMEDha pasado de 12.6% a 34.3% en los últimos 5 años.
Cobertura de la deuda: AMEDLa deuda de la empresa está bien cubierta por el flujo de caja operativo (31.4%).
Cobertura de intereses: AMEDLos pagos de intereses de su deuda están bien cubiertos por el EBIT (7.4x cobertura).